Class information for:
Level 1: C3 AND C4//COMPLEMENT AND INFLAMMATION//LUPUS EXCELLENCE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
22658 317 28.9 51%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
332 17329 COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 C3 AND C4 Author keyword 1 50% 1% 2
2 COMPLEMENT AND INFLAMMATION Journal 1 12% 3% 10
3 LUPUS EXCELLENCE Address 1 16% 2% 5
4 ABT ZELLULARE MOL IMMUNOL Address 1 50% 0% 1
5 ANTI COMPLEMENT THERAPY Author keyword 1 50% 0% 1
6 C4C Author keyword 1 50% 0% 1
7 CELL BOUND COMPLEMENT ACTIVATION PRODUCTS Author keyword 1 50% 0% 1
8 CLASSICAL AND ALTERNATIVE PATHWAYS Author keyword 1 50% 0% 1
9 ELEA Author keyword 1 50% 0% 1
10 ELISA QUANTIFICATION Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 C3 AND C4 1 50% 1% 2 Search C3+AND+C4 Search C3+AND+C4
2 ANTI COMPLEMENT THERAPY 1 50% 0% 1 Search ANTI+COMPLEMENT+THERAPY Search ANTI+COMPLEMENT+THERAPY
3 C4C 1 50% 0% 1 Search C4C Search C4C
4 CELL BOUND COMPLEMENT ACTIVATION PRODUCTS 1 50% 0% 1 Search CELL+BOUND+COMPLEMENT+ACTIVATION+PRODUCTS Search CELL+BOUND+COMPLEMENT+ACTIVATION+PRODUCTS
5 CLASSICAL AND ALTERNATIVE PATHWAYS 1 50% 0% 1 Search CLASSICAL+AND+ALTERNATIVE+PATHWAYS Search CLASSICAL+AND+ALTERNATIVE+PATHWAYS
6 ELEA 1 50% 0% 1 Search ELEA Search ELEA
7 ELISA QUANTIFICATION 1 50% 0% 1 Search ELISA+QUANTIFICATION Search ELISA+QUANTIFICATION
8 ALTERNATIVE PATHWAY ACTIVATION 1 29% 1% 2 Search ALTERNATIVE+PATHWAY+ACTIVATION Search ALTERNATIVE+PATHWAY+ACTIVATION
9 C4D IMMUNOSTAIN 0 33% 0% 1 Search C4D+IMMUNOSTAIN Search C4D+IMMUNOSTAIN
10 CLASSICAL PATHWAY ACTIVATION 0 33% 0% 1 Search CLASSICAL+PATHWAY+ACTIVATION Search CLASSICAL+PATHWAY+ACTIVATION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 FACTOR B ACTIVATION 6 71% 2% 5
2 SPLIT PRODUCTS 3 38% 2% 6
3 C1 ACTIVATION 2 67% 1% 2
4 PLATELET C4D 1 100% 1% 2
5 ACTIVATION PRODUCTS 1 18% 2% 6
6 C 3 ANAPHYLATOXIN LEVELS 1 40% 1% 2
7 NEOEPITOPE 1 16% 2% 5
8 ANTI ALPHA ACTININ 1 50% 0% 1
9 CD4CD25 FOXP3 T CELLS 1 50% 0% 1
10 FRAGMENT BA 1 50% 0% 1

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 COMPLEMENT AND INFLAMMATION 1 12% 3% 10

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
An international serum standard for application in assays to detect human complement activation products 2013 8 17 24%
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 2011 21 87 15%
The complement systemin systemic lupus erythematosus 2002 10 23 22%
REVIEW - ASSESSMENT OF COMPLEMENT ACTIVATION IN CLINICAL IMMUNOLOGY LABORATORIES - TIME FOR REAPPRAISAL 1989 12 55 47%
CLINICAL COMPLEMENTOLOGY - RECENT PROGRESS AND FUTURE-TRENDS 1994 46 70 13%
Validation of new biomarkers in systemic autoimmune diseases 2011 7 67 13%
Biomarkers for systemic lupus erythematosus: a review and perspective 2005 31 76 8%
MEASUREMENT OF THE COMPLEMENT-SYSTEM - GENERAL-PRINCIPLES AND PROSPECTS 1990 3 53 32%
COMPLEMENT AND LUPUS - OLD CONCEPTS AND NEW DIRECTIONS 1992 5 37 27%
APPLICATIONS OF COMPLEMENT DETERMINATIONS IN HUMAN-DISEASE 1994 6 9 22%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 LUPUS EXCELLENCE 1 16% 1.6% 5
2 ABT ZELLULARE MOL IMMUNOL 1 50% 0.3% 1
3 FDN ESPANOLA REUMATOL 1 50% 0.3% 1
4 IMMUNOL IMM 18 1 50% 0.3% 1
5 MED MASSACHUSETTS GEN HOSP DERMATOL 1 50% 0.3% 1
6 NEPHROL KIDNEY TRANSPLANTAT SECT 1 50% 0.3% 1
7 RIGSHOSP MED TTA 1 50% 0.3% 1
8 KN P AFTKRANKENHAUS 0 25% 0.3% 1
9 MOL MED CLIN IMMUNOL 0 17% 0.3% 1
10 BIOMED ENGN ARTIFICIAL HEART 0 100% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000192864 COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1
2 0.0000180631 C8 ALPHA//C8 GAMMA//PROPERDIN DEFICIENCY
3 0.0000172560 IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX//LOW MOLECULAR WEIGHT IGM
4 0.0000170272 C2 DEFICIENCY//COMPLEMENT GENETICS//COMPLEMENT AND INFLAMMATION
5 0.0000165514 C5A//C5A RECEPTOR//C5AR
6 0.0000132063 ANTIBODY TO HEPATITIS C VIRUS//ANGIONEUROL//ANTIGEN ANTIBODY DOCKING
7 0.0000123717 C1Q//C1Q DEFICIENCY//ANTI C1Q ANTIBODIES
8 0.0000101390 ATYPICAL HEMOLYTIC UREMIC SYNDROME//FACTOR H//C3 GLOMERULOPATHY
9 0.0000096452 COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO
10 0.0000091281 RHEUMATOID VASCULITIS//RHEUMATOID MYOSITIS//EXTRAARTICULAR MANIFESTATIONS